Myeroff LL - Search Results

1

Increased nm23-H1 and nm23-H2 messenger RNA expression and absence of mutations in colon carcinomas of low and high metastatic potential.

Myeroff LL, Markowitz SD. Myeroff LL, et al. J Natl Cancer Inst. 1993 Jan 20;85(2):147-52. doi: 10.1093/jnci/85.2.147. J Natl Cancer Inst. 1993. PMID: 8418304

2

HLTF gene silencing in human colon cancer.

Moinova HR, Chen WD, Shen L, Smiraglia D, Olechnowicz J, Ravi L, Kasturi L, Myeroff L, Plass C, Parsons R, Minna J, Willson JK, Green SB, Issa JP, Markowitz SD. Moinova HR, et al. Proc Natl Acad Sci U S A. 2002 Apr 2;99(7):4562-7. doi: 10.1073/pnas.062459899. Epub 2002 Mar 19. Proc Natl Acad Sci U S A. 2002. PMID: 11904375 Free PMC article.

3

Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene.

Chen WD, Han ZJ, Skoletsky J, Olson J, Sah J, Myeroff L, Platzer P, Lu S, Dawson D, Willis J, Pretlow TP, Lutterbaugh J, Kasturi L, Willson JK, Rao JS, Shuber A, Markowitz SD. Chen WD, et al. J Natl Cancer Inst. 2005 Aug 3;97(15):1124-32. doi: 10.1093/jnci/dji204. J Natl Cancer Inst. 2005. PMID: 16077070

4

Mutation of the type II transforming growth factor-beta receptor is coincident with the transformation of human colon adenomas to malignant carcinomas.

Grady WM, Rajput A, Myeroff L, Liu DF, Kwon K, Willis J, Markowitz S. Grady WM, et al. Cancer Res. 1998 Jul 15;58(14):3101-4. Cancer Res. 1998. PMID: 9679977

5

Nm23--into the basement (membrane).

Myeroff LL, Markowitz SD. Myeroff LL, et al. J Natl Cancer Inst. 1994 Dec 21;86(24):1815-7. doi: 10.1093/jnci/86.24.1815. J Natl Cancer Inst. 1994. PMID: 7990152 No abstract available.

6

Mutational inactivation of transforming growth factor beta receptor type II in microsatellite stable colon cancers.

Grady WM, Myeroff LL, Swinler SE, Rajput A, Thiagalingam S, Lutterbaugh JD, Neumann A, Brattain MG, Chang J, Kim SJ, Kinzler KW, Vogelstein B, Willson JK, Markowitz S. Grady WM, et al. Among authors: myeroff ll. Cancer Res. 1999 Jan 15;59(2):320-4. Cancer Res. 1999. PMID: 9927040

7

BCL9 promotes tumor progression by conferring enhanced proliferative, metastatic, and angiogenic properties to cancer cells.

Mani M, Carrasco DE, Zhang Y, Takada K, Gatt ME, Dutta-Simmons J, Ikeda H, Diaz-Griffero F, Pena-Cruz V, Bertagnolli M, Myeroff LL, Markowitz SD, Anderson KC, Carrasco DR. Mani M, et al. Among authors: myeroff ll. Cancer Res. 2009 Oct 1;69(19):7577-86. doi: 10.1158/0008-5472.CAN-09-0773. Epub 2009 Sep 8. Cancer Res. 2009. PMID: 19738061 Free PMC article.

8

Induction of KIAA1199/CEMIP is associated with colon cancer phenotype and poor patient survival.

Fink SP, Myeroff LL, Kariv R, Platzer P, Xin B, Mikkola D, Lawrence E, Morris N, Nosrati A, Willson JK, Willis J, Veigl M, Barnholtz-Sloan JS, Wang Z, Markowitz SD. Fink SP, et al. Among authors: myeroff ll. Oncotarget. 2015 Oct 13;6(31):30500-15. doi: 10.18632/oncotarget.5921. Oncotarget. 2015. PMID: 26437221 Free PMC article.

9

Transposon mutagenesis identifies candidate genes that cooperate with loss of transforming growth factor-beta signaling in mouse intestinal neoplasms.

Morris SM, Davison J, Carter KT, O'Leary RM, Trobridge P, Knoblaugh SE, Myeroff LL, Markowitz SD, Brett BT, Scheetz TE, Dupuy AJ, Starr TK, Grady WM. Morris SM, et al. Among authors: myeroff ll. Int J Cancer. 2017 Feb 15;140(4):853-863. doi: 10.1002/ijc.30491. Epub 2016 Nov 7. Int J Cancer. 2017. PMID: 27790711 Free PMC article.

10

Chromosomal autonomy of hMLH1 methylation in colon cancer.

Li H, Myeroff L, Kasturi L, Krumroy L, Schwartz S, Willson JK, Stanbridge E, Casey G, Markowitz S. Li H, et al. Oncogene. 2002 Feb 21;21(9):1443-9. doi: 10.1038/sj.onc.1205247. Oncogene. 2002. PMID: 11857087

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

28 results

Search Page